Loading...
XSHG
600479
Market cap570mUSD
Jul 09, Last price  
9.45CNY
1D
-1.05%
1Q
-11.93%
Jan 2017
-28.08%
IPO
103.23%
Name

ZhuZhou QianJin Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHG:600479 chart
P/E
13.52
P/S
1.06
EPS
0.70
Div Yield, %
3.81%
Shrs. gr., 5y
1.40%
Rev. gr., 5y
0.04%
Revenues
3.63b
+0.13%
602,686,103679,777,224801,429,486904,270,114979,443,7661,256,527,2711,583,422,7321,972,855,0852,194,240,4692,446,684,0742,864,885,5113,182,743,7913,328,553,9633,525,238,1213,626,966,8083,663,844,6124,026,278,5923,798,485,3293,629,804,4913,634,578,070
Net income
286m
+24.07%
71,778,673173,619,322129,892,010130,913,57986,382,77982,821,345120,164,486123,767,871105,092,91592,959,635149,428,675207,758,273255,355,307294,313,219297,071,600302,063,357302,508,851320,405,841230,756,623286,293,094
CFO
480m
+20.43%
120,122,93979,263,36137,204,11773,541,73039,129,91622,578,202197,816,674137,632,243183,342,68867,484,546140,879,318283,466,753383,466,469155,493,890542,373,092485,573,058733,472,924443,115,163398,766,454480,244,967
Dividend
Jul 25, 20250.36 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in 1993 and headquartered in Zhuzhou, China, ZhuZhou QianJin Pharmaceutical Co.,Ltd operates as a leading manufacturer and distributor of pharmaceutical goods throughout China. The company boasts a comprehensive product portfolio, encompassing treatments for women's health, pediatric ailments, dermatological concerns, anti-infectives, and conditions affecting the circulatory, endocrine, digestive, nervous, and cardiovascular systems. Additionally, they offer specialized medications and traditional Chinese remedies. These diverse pharmaceutical offerings are presented in various formats, including pills, tablets, capsules, granules, powders, decoctions, and liquid solutions. Beyond its core pharmaceutical business, ZhuZhou QianJin also produces ginger-based beverages, feminine hygiene products, and alcoholic beverages.
IPO date
Mar 12, 2004
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT